Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Interim Management Statement

15 May 2012 07:00

RNS Number : 3180D
Tarsus Group PLC
15 May 2012
 



15 May 2012

TARSUS GROUP plc

 

Interim Management Statement

 

Tarsus Group plc (LSE: TRS, "Tarsus" or the "Group"), the international business-to-business media group, is today publishing its Interim Management Statement for the period from 8 March 2012 to 14 May 2012.

 

Overview

 

Trading for the period has been in line with the Board's expectations and forward bookings for the year to 31 December 2012 now stand at 65% of anticipated full year revenues, compared to 61% at the same time in 2010.

 

Bookings are tracking 15% ahead of last year (as adjusted for biennial events). Revenues are heavily weighted towards the second half of the year owing to the timing of exhibitions.

 

The Group's growth prospects have been transformed over the last 12 months. A number of lower growth businesses have been sold whilst the Group has made key acquisitions in China and Turkey. Tarsus has developed a high quality portfolio of international fast growth events in emerging markets and the Board is confident of reaching its 50/13 target to derive 50% of revenues from emerging markets in 2013.

 

Emerging markets

 

The Group's emerging markets businesses continues to gain momentum through a combination of strong revenue growth and the successful integration of recent acquisitions.

 

IFO in Turkey, acquired in June 2011, is performing well. Sales for IFO's next exhibition, REW Istanbul, the international recycling, environmental technologies and waste management event to be held in June 2012, are tracking significantly ahead of the 2011 edition.

 

The integration of Life Media in Turkey, acquired in March 2012, is on track. Life Media's first exhibition under Tarsus ownership, Ideal Home, Turkey's leading Housewares & Gifts event, was held in April 2012 and produced an excellent performance with revenues up 50% on the 2011 edition.

 

Trading in the Chinese business continues to be very strong. The Group's exposure to China will be increased significantly by the acquisition of 50% of the China International Automotive Aftermarket Industry and Tuning (Guangzhou) Trade Fair ("GZ Auto") and other associated business assets, which is expected to complete in the next three months. GZ Auto is a leading business-to-business automotive aftermarket exhibition held annually in China. The joint venture will provide Tarsus with exposure to the vibrant automotive industry in China.

 

The Group's largest event in Dubai in 2012 is MEBA (business aviation). Forward bookings for this event are tracking ahead of the previous event.

 

US

 

The Medical division continues to grow strongly. This has been driven by its education programmes, including those now delivered online. The 20th Annual World Congress on Anti-Aging & Regenerative Medicine will be held in Orlando later this week and it is expected that this event will be well ahead of the previous edition. The Medical division's remaining 2012 order book is strong.

 

The February 2012 Off-Price Show in Las Vegas performed well, with revenues up 7%. Bookings for the August 2012 Off-Price Show in Las Vegas are tracking ahead of the 2011 edition.

 

Labelexpo Americas will be held in Chicago in September 2012. Bookings are strong and it is expected to outperform its previous edition.

 

Europe

 

Trading in the Group's French division has been slightly better than expected. However, given the current economic and political uncertainty in Europe, Tarsus remains cautious for the full year, particularly given the occurrence of the largest French shows in the second half of 2012 and the current weakness of the Euro.

 

Financial Position

 

There have been no significant changes to the financial position of the Group since the publication of the Annual Results on 7 March 2012.

 

 

Douglas Emslie, Tarsus Group Managing Director, said:

 

"We have transformed the Group and its growth prospects in the last 12 months through a combination of acquisitions in Turkey and China and the disposal of a significant part of our French operations - in line with our 50/13 strategy, which is now substantially complete.

 

"We now have a high quality portfolio addressing growth markets in fast growing economies worldwide. We are focussed on driving visitor traffic and growing exhibition volumes as we seek to maximise the benefits of our unique and diversified portfolio in order to accelerate earnings growth."

 

The Group expects to publish its interim results for the six months ending 30 June 2012 on 25 July 2012.

 

For further information:

 

Tarsus Group plc:

Douglas Emslie, Group Managing Director 020 8846 2700

Dan O'Brien, Group Finance Director

 

College Hill:

Adrian Duffield /Kay Larsen 020 7457 2020

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBKQDBABKDKPD
Date   Source Headline
8th Dec 20164:35 pmRNSHolding(s) in Company
8th Dec 20164:33 pmRNSHolding(s) in Company
8th Dec 20164:31 pmRNSHolding(s) in Company
8th Dec 20164:29 pmRNSHolding(s) in Company
8th Dec 20167:00 amRNSCompletion of Acquisition
7th Dec 20169:00 amRNSAdmission of Placing Shares
5th Dec 201612:30 pmRNSCompletion of Placing
5th Dec 20167:00 amRNSProposed Placing and Acquisition
1st Dec 201610:46 amRNSTotal Voting Rights
22nd Nov 20167:00 amRNSCapital Markets Event and Trading Update
9th Nov 20163:19 pmRNSBlock listing Interim Review
31st Oct 20169:52 amRNSTotal Voting Rights
13th Oct 20167:24 amRNSDirector/PDMR Shareholding
12th Oct 20167:00 amRNSTrading Update
30th Sep 20169:53 amRNSTotal Voting Rights and Capital
1st Sep 201612:09 pmRNSTotal Voting Rights
15th Aug 20165:28 pmRNSInterim financial statements
9th Aug 20166:11 pmRNSHolding(s) in Company
29th Jul 201612:10 pmRNSTotal Voting Rights and Capital
27th Jul 20167:00 amRNSHalf-year Report
11th Jul 20161:30 pmRNSApplication for Admission
5th Jul 20161:12 pmRNSHolding(s) in Company
30th Jun 201612:28 pmRNSTotal Voting Rights
21st Jun 20164:42 pmRNSDirector/PDMR Shareholding
20th Jun 20164:00 pmRNSResult of AGM
7th Jun 20161:15 pmRNSDirector/PDMR Shareholding
3rd Jun 20162:58 pmRNSScrip Dividend Circular (the "Circular")
31st May 201611:59 amRNSTotal Voting Rights and Capital
17th May 20163:08 pmRNSNotice of 2016 Annual General Meeting
17th May 20167:00 amRNSTrading Update
11th May 20167:00 amRNSDirector/PDMR Shareholding
9th May 20163:43 pmRNSBlock Listing Six Monthly Return
29th Apr 20164:14 pmRNSTotal Voting Rights
31st Mar 20162:25 pmRNSTotal Voting Rights
31st Mar 20162:24 pmRNSDirector/PDMR Shareholding
21st Mar 20163:11 pmRNS2015 Annual Report
8th Mar 20165:55 pmRNSDirector/PDMR Shareholding
3rd Mar 20164:47 pmRNSDirector/PDMR Shareholding
2nd Mar 20167:00 amRNSFinal Results
2nd Feb 20163:48 pmRNSTotal Voting Rights and Capital
25th Jan 20161:05 pmRNSApplication for Admission
12th Jan 20167:00 amRNSYear-end trading update
31st Dec 20159:25 amRNSTotal Voting Rights
14th Dec 20155:07 pmRNSScrip dividend circular
8th Dec 20157:00 amRNSCapital markets presentation
2nd Dec 20153:49 pmRNSDirector/PDMR Shareholding
30th Nov 20154:35 pmRNSTotal Voting Rights
11th Nov 201510:00 amRNSBlock Listing Six Monthly Return
30th Oct 20153:22 pmRNSDirector/PDMR Shareholding
30th Oct 20153:20 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.